On TV.com: MILEY CYRUS photos
Find Articles in:
all
Business
Reference
Technology
News
Sports
Health
Autos
Arts
Home & Garden
advertisement
advertisement

Content provided in partnership with
Thomson / Gale

BioStratum Inc

BT Catalyst,  Sept, 2002  

BioStratum Inc. of Research Triangle Park has received Fast Track status from the FDA for Pyridorin[TM], its lead drug candidate for diabetic kidney disease. To receive the status, a drug candidate must be intended for the treatment of a serious or life-threatening condition, and demonstrate the potential to address significant unmet medical needs for the condition.

Pyridorin[TM] is in Phase II clinical trials.

COPYRIGHT 2002 North Carolina Biotechnology Center
COPYRIGHT 2008 Gale, Cengage Learning